Kamada Ltd Corporate Update Call Transcript
Greetings and welcome to Kamaa Corporate Update conference call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone requires operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Brian Ritchie, managing director of Lifeci Advisors.
Thank you. Please go ahead.
Thank you. This is Brian Richie with Lifesty Advisors, and thank you all for participating in today's call. Joining me from Kamata are Amir London, Chief Executive Officer, and Jaime Orlev, Chief Financial Officer. Earlier today, Kamata issued a press release announcing the company's decision to discontinue its Phase 3 inhaled AAT Innovate clinical trial while providing an update on its financial projections, which are the subject of today's corporate update call.
If you have not
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
